| Original language | English (US) |
|---|---|
| Pages (from-to) | 333-340 |
| Number of pages | 8 |
| Journal | International Journal of Radiation Oncology Biology Physics |
| Volume | 117 |
| Issue number | 2 |
| DOIs | |
| State | Published - Oct 1 2023 |
ASJC Scopus subject areas
- Radiation
- Oncology
- Radiology Nuclear Medicine and imaging
- Cancer Research
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: International Journal of Radiation Oncology Biology Physics, Vol. 117, No. 2, 01.10.2023, p. 333-340.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Final Report of NRG Oncology RTOG 0022
T2 - A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer
AU - Garden, Adam S.
AU - Harris, Jonathan
AU - Eisbruch, Avraham
AU - Chao, K. S.Clifford
AU - Morrison, William H.
AU - Harari, Paul M.
AU - Swanson, Todd Allen
AU - Jones, Christopher U.
AU - Yom, Sue S.
AU - Spencer, Sharon A.
AU - Scrimger, Rufus
AU - Shenouda, George
AU - Shukla, Monica
AU - Lau, Harold Y.
AU - Mierzwa, Michelle
AU - Torres-Saavedra, Pedro
AU - Le, Quynh Thu
N1 - Funding Information: Disclosures: Q.T.L. reports support for attending meetings and/or travel from the Radiation Therapy Oncology Group (RTOG) Foundation and a leadership role as RTOG group chair (NRG Oncology). M.M. reports that Bristol-Myers Squibb supplied drugs for clinical trial UMCC 2018.085. In addition, she received academic support from Debio and holds a leadership role with the International Journal of Radiation Oncology • Biology • Physics as associate editor for the head and neck section. P.T.-S. reports support for the present article from NRG Oncology SDMC and the grant from the National Cancer Institute. S.S.Y. reports grants or contracts paid to her institution for research support from Genentech, BioMimetix, Merck, EMD Serono, and Bristol-Myers Squibb; royalties or licenses from UpToDate and Springer; and payment or honoraria for lectures or presentations from the American Society for Radiation Oncology and Elsevier. She is also a past president of the American Radium Society. The remaining authors have no disclosures to report. Funding Information: This project was supported by grants U10CA180868 (NRG Oncology Operations), U10CA180822 (NRG Oncology Statistical and Data Management Center), and U24CA180803 (Imaging and Radiation Oncology Center) from the National Cancer Institute. Disclosures: Q.T.L. reports support for attending meetings and/or travel from the Radiation Therapy Oncology Group (RTOG) Foundation and a leadership role as RTOG group chair (NRG Oncology). M.M. reports that Bristol-Myers Squibb supplied drugs for clinical trial UMCC 2018.085. In addition, she received academic support from Debio and holds a leadership role with the International Journal of Radiation Oncology • Biology • Physics as associate editor for the head and neck section. P.T.-S. reports support for the present article from NRG Oncology SDMC and the grant from the National Cancer Institute. S.S.Y. reports grants or contracts paid to her institution for research support from Genentech, BioMimetix, Merck, EMD Serono, and Bristol-Myers Squibb; royalties or licenses from UpToDate and Springer; and payment or honoraria for lectures or presentations from the American Society for Radiation Oncology and Elsevier. She is also a past president of the American Radium Society. The remaining authors have no disclosures to report.
PY - 2023/10/1
Y1 - 2023/10/1
UR - http://www.scopus.com/inward/record.url?scp=85152420386&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85152420386&partnerID=8YFLogxK
U2 - 10.1016/j.ijrobp.2023.02.057
DO - 10.1016/j.ijrobp.2023.02.057
M3 - Article
C2 - 36925074
AN - SCOPUS:85152420386
SN - 0360-3016
VL - 117
SP - 333
EP - 340
JO - International Journal of Radiation Oncology Biology Physics
JF - International Journal of Radiation Oncology Biology Physics
IS - 2
ER -